Manipal Health Enterprises Ltd.
•2026-08-21
PROS
- Promoters have been increasing their shareholding - up 13.3pp over 2 years
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 41.6% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.99x)
- Working capital cycle has improved - days down from 47 to 26
- Institutional investors have been accumulating - FII+DII up 8.9pp
CONS
- Receivables are growing faster than sales - a possible quality concern
- Equity base is being diluted - shares outstanding up 212.0%
- Total debt has risen sharply - up 115.8% year on year
- Recurring exceptional / one-off items are inflating headline profit
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Expensive relative to growth - PEG of 3.8
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | RAINBOW | 1461.10 | 52.00 | 14839.90 | 0.24 | 62.54 | 16.23 | 469.99 | 33.17 | 28.25 | 28.65 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,398 | 1,567 | 1,794 | 2,025 | 1,813 | 3,975 | 4,806 | 6,172 | 8,242 | 10,336 | |
| 1,204 | 1,335 | 1,528 | 1,622 | 1,483 | 3,076 | 3,562 | 4,492 | 6,153 | 7,725 | |
| Operating Profit | 240 | 270 | 295 | 438 | 388 | 1,009 | 1,332 | 1,777 | 2,247 | 2,796 |
| OPM % | 17 | 17 | 16 | 22 | 21 | 25 | 28 | 29 | 27 | 27 |
| Other Income | 47 | 39 | 29 | 35 | 58 | 109 | 88 | 97 | 157 | 185 |
| Interest | 155 | 170 | 180 | 211 | 205 | 326 | 329 | 455 | 512 | 864 |
| Depreciation | 134 | 163 | 213 | 175 | 183 | 256 | 315 | 397 | 507 | 680 |
| -59 | -94 | -109 | 110 | -86 | 637 | 586 | 745 | 1,242 | 1,178 | |
| Tax % | 32 | 13 | -23 | 42 | -37 | 14 | 27 | 28 | 13 | 22 |
| Net Profit | -40 | -82 | -135 | 64 | -117 | 547 | 429 | 533 | 1,082 | 917 |
| EPS | -6 | -12 | -20 | 8 | -20 | 72 | 57 | 79 | 138 | 8 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 3 | -1 | 0 | 2 | 0 | -2 | 61 | -16 | -24 |
| Share of Associates | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | -1 | -1 | 1 | -1 | 5 | 4 | 5 | 46 | 8 |
| Minority Interest | 0 | 3 | -1 | 0 | 2 | 0 | -2 | 61 | -16 | -24 |
| Share of Associates | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | -1 | -1 | 1 | -1 | 5 | 4 | 5 | 46 | 8 |
- 1,398
- 1,204
- Operating Profit
- 240
- OPM %
- 17
- Other Income
- 47
- Interest
- 155
- Depreciation
- 134
- -59
- Tax %
- 32
- Net Profit
- -40
- EPS
- -6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- 1,567
- 1,335
- Operating Profit
- 270
- OPM %
- 17
- Other Income
- 39
- Interest
- 170
- Depreciation
- 163
- -94
- Tax %
- 13
- Net Profit
- -82
- EPS
- -12
- Dividend Payout %
- 0
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -1
- 1,794
- 1,528
- Operating Profit
- 295
- OPM %
- 16
- Other Income
- 29
- Interest
- 180
- Depreciation
- 213
- -109
- Tax %
- -23
- Net Profit
- -135
- EPS
- -20
- Dividend Payout %
- 0
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- -1
- 2,025
- 1,622
- Operating Profit
- 438
- OPM %
- 22
- Other Income
- 35
- Interest
- 211
- Depreciation
- 175
- 110
- Tax %
- 42
- Net Profit
- 64
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- 1,813
- 1,483
- Operating Profit
- 388
- OPM %
- 21
- Other Income
- 58
- Interest
- 205
- Depreciation
- 183
- -86
- Tax %
- -37
- Net Profit
- -117
- EPS
- -20
- Dividend Payout %
- 0
- Minority Interest
- 2
- Share of Associates
- -1
- Adjusted EPS
- -1
- Minority Interest
- 2
- Share of Associates
- -1
- Adjusted EPS
- -1
- 3,975
- 3,076
- Operating Profit
- 1,009
- OPM %
- 25
- Other Income
- 109
- Interest
- 326
- Depreciation
- 256
- 637
- Tax %
- 14
- Net Profit
- 547
- EPS
- 72
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- 4,806
- 3,562
- Operating Profit
- 1,332
- OPM %
- 28
- Other Income
- 88
- Interest
- 329
- Depreciation
- 315
- 586
- Tax %
- 27
- Net Profit
- 429
- EPS
- 57
- Dividend Payout %
- 0
- Minority Interest
- -2
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- -2
- Share of Associates
- 0
- Adjusted EPS
- 4
- 6,172
- 4,492
- Operating Profit
- 1,777
- OPM %
- 29
- Other Income
- 97
- Interest
- 455
- Depreciation
- 397
- 745
- Tax %
- 28
- Net Profit
- 533
- EPS
- 79
- Dividend Payout %
- 0
- Minority Interest
- 61
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 61
- Share of Associates
- 0
- Adjusted EPS
- 5
- 8,242
- 6,153
- Operating Profit
- 2,247
- OPM %
- 27
- Other Income
- 157
- Interest
- 512
- Depreciation
- 507
- 1,242
- Tax %
- 13
- Net Profit
- 1,082
- EPS
- 138
- Dividend Payout %
- 0
- Minority Interest
- -16
- Share of Associates
- 0
- Adjusted EPS
- 46
- Minority Interest
- -16
- Share of Associates
- 0
- Adjusted EPS
- 46
- 10,336
- 7,725
- Operating Profit
- 2,796
- OPM %
- 27
- Other Income
- 185
- Interest
- 864
- Depreciation
- 680
- 1,178
- Tax %
- 22
- Net Profit
- 917
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- -24
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- -24
- Share of Associates
- 0
- Adjusted EPS
- 8
COMPOUNDED SALES GROWTH
- 10 Years:
- 23%
- 5 Years:
- 42%
- 3 Years:
- 29%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 28%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 7%
- 5 Years:
- 18%
- 3 Years:
- 17%
- Last Year:
- 13%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 69 | 69 | 69 | 69 | 69 | 76 | 76 | 76 | 77 | 236 |
| 1,311 | 1,260 | 1,126 | 1,191 | 1,064 | 2,714 | 3,144 | 3,938 | 5,730 | 8,116 | |
| 31 | 0 | 0 | 0 | 125 | 370 | 201 | 0 | 0 | 0 | |
| Trade Payables | 136 | 218 | 296 | 335 | 423 | 668 | 767 | 1,131 | 1,127 | 1,465 |
| 1,528 | 1,919 | 2,021 | 2,583 | 2,344 | 3,519 | 3,576 | 5,613 | 6,957 | 14,918 | |
| Total Liabilities | 3,074 | 3,465 | 3,511 | 4,177 | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 2,104 | 2,531 | 2,558 | 3,071 | 2,239 | 4,484 | 4,742 | 8,158 | 9,826 | 18,753 | |
| Capital Work in Progress | 63 | 62 | 61 | 92 | 13 | 208 | 40 | 42 | 614 | 795 |
| 376 | 373 | 333 | 444 | 551 | 866 | 1,080 | 1,121 | 1,776 | 2,675 | |
| 41 | 36 | 40 | 43 | 23 | 77 | 63 | 103 | 132 | 170 | |
| 127 | 140 | 158 | 144 | 131 | 298 | 309 | 459 | 637 | 930 | |
| Cash & Bank | 29 | 38 | 75 | 67 | 23 | 162 | 162 | 380 | 330 | 323 |
| 334 | 285 | 286 | 316 | 1,045 | 1,251 | 1,367 | 495 | 575 | 1,088 | |
| Total Assets | 3,074 | 3,465 | 3,511 | 4,177 | 4,024 | 7,346 | 7,763 | 10,757 | 13,890 | 24,735 |
| Total Debt | 1,341 | 1,643 | 1,735 | 1,806 | 1,575 | 1,974 | 2,150 | 3,944 | 4,767 | 10,288 |
| Net Working Capital | 374 | 154 | 42 | 36 | -153 | -386 | 374 | 395 | 1,053 | 740 |
| Contingent Liabilities | 44 | 45 | 99 | 104 | 125 | 818 | 852 | 268 | 234 | 146 |
| Book Value per Share | 200.83 | 193.40 | 173.98 | 183.33 | 164.86 | 368.91 | 425.70 | 530.69 | 753.50 | 70.80 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 |
| Total Debt | 1,341 | 1,643 | 1,735 | 1,806 | 1,575 | 1,974 | 2,150 | 3,944 | 4,767 | 10,288 |
| Net Working Capital | 374 | 154 | 42 | 36 | -153 | -386 | 374 | 395 | 1,053 | 740 |
| Contingent Liabilities | 44 | 45 | 99 | 104 | 125 | 818 | 852 | 268 | 234 | 146 |
| Book Value per Share | 200.83 | 193.40 | 173.98 | 183.33 | 164.86 | 368.91 | 425.70 | 530.69 | 753.50 | 70.80 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 |
- Equity Capital
- 69
- 1,311
- 31
- Trade Payables
- 136
- 1,528
- Total Liabilities
- 3,074
- 2,104
- Capital Work in Progress
- 63
- 376
- 41
- 127
- Cash & Bank
- 29
- 334
- Total Assets
- 3,074
- Total Debt
- 1,341
- Net Working Capital
- 374
- Contingent Liabilities
- 44
- Book Value per Share
- 200.83
- Face Value
- 10.00
- Total Debt
- 1,341
- Net Working Capital
- 374
- Contingent Liabilities
- 44
- Book Value per Share
- 200.83
- Face Value
- 10.00
- Equity Capital
- 69
- 1,260
- 0
- Trade Payables
- 218
- 1,919
- Total Liabilities
- 3,465
- 2,531
- Capital Work in Progress
- 62
- 373
- 36
- 140
- Cash & Bank
- 38
- 285
- Total Assets
- 3,465
- Total Debt
- 1,643
- Net Working Capital
- 154
- Contingent Liabilities
- 45
- Book Value per Share
- 193.40
- Face Value
- 10.00
- Total Debt
- 1,643
- Net Working Capital
- 154
- Contingent Liabilities
- 45
- Book Value per Share
- 193.40
- Face Value
- 10.00
- Equity Capital
- 69
- 1,126
- 0
- Trade Payables
- 296
- 2,021
- Total Liabilities
- 3,511
- 2,558
- Capital Work in Progress
- 61
- 333
- 40
- 158
- Cash & Bank
- 75
- 286
- Total Assets
- 3,511
- Total Debt
- 1,735
- Net Working Capital
- 42
- Contingent Liabilities
- 99
- Book Value per Share
- 173.98
- Face Value
- 10.00
- Total Debt
- 1,735
- Net Working Capital
- 42
- Contingent Liabilities
- 99
- Book Value per Share
- 173.98
- Face Value
- 10.00
- Equity Capital
- 69
- 1,191
- 0
- Trade Payables
- 335
- 2,583
- Total Liabilities
- 4,177
- 3,071
- Capital Work in Progress
- 92
- 444
- 43
- 144
- Cash & Bank
- 67
- 316
- Total Assets
- 4,177
- Total Debt
- 1,806
- Net Working Capital
- 36
- Contingent Liabilities
- 104
- Book Value per Share
- 183.33
- Face Value
- 10.00
- Total Debt
- 1,806
- Net Working Capital
- 36
- Contingent Liabilities
- 104
- Book Value per Share
- 183.33
- Face Value
- 10.00
- Equity Capital
- 69
- 1,064
- 125
- Trade Payables
- 423
- 2,344
- Total Liabilities
- 4,024
- 2,239
- Capital Work in Progress
- 13
- 551
- 23
- 131
- Cash & Bank
- 23
- 1,045
- Total Assets
- 4,024
- Total Debt
- 1,575
- Net Working Capital
- -153
- Contingent Liabilities
- 125
- Book Value per Share
- 164.86
- Face Value
- 10.00
- Total Debt
- 1,575
- Net Working Capital
- -153
- Contingent Liabilities
- 125
- Book Value per Share
- 164.86
- Face Value
- 10.00
- Equity Capital
- 76
- 2,714
- 370
- Trade Payables
- 668
- 3,519
- Total Liabilities
- 7,346
- 4,484
- Capital Work in Progress
- 208
- 866
- 77
- 298
- Cash & Bank
- 162
- 1,251
- Total Assets
- 7,346
- Total Debt
- 1,974
- Net Working Capital
- -386
- Contingent Liabilities
- 818
- Book Value per Share
- 368.91
- Face Value
- 10.00
- Total Debt
- 1,974
- Net Working Capital
- -386
- Contingent Liabilities
- 818
- Book Value per Share
- 368.91
- Face Value
- 10.00
- Equity Capital
- 76
- 3,144
- 201
- Trade Payables
- 767
- 3,576
- Total Liabilities
- 7,763
- 4,742
- Capital Work in Progress
- 40
- 1,080
- 63
- 309
- Cash & Bank
- 162
- 1,367
- Total Assets
- 7,763
- Total Debt
- 2,150
- Net Working Capital
- 374
- Contingent Liabilities
- 852
- Book Value per Share
- 425.70
- Face Value
- 10.00
- Total Debt
- 2,150
- Net Working Capital
- 374
- Contingent Liabilities
- 852
- Book Value per Share
- 425.70
- Face Value
- 10.00
- Equity Capital
- 76
- 3,938
- 0
- Trade Payables
- 1,131
- 5,613
- Total Liabilities
- 10,757
- 8,158
- Capital Work in Progress
- 42
- 1,121
- 103
- 459
- Cash & Bank
- 380
- 495
- Total Assets
- 10,757
- Total Debt
- 3,944
- Net Working Capital
- 395
- Contingent Liabilities
- 268
- Book Value per Share
- 530.69
- Face Value
- 10.00
- Total Debt
- 3,944
- Net Working Capital
- 395
- Contingent Liabilities
- 268
- Book Value per Share
- 530.69
- Face Value
- 10.00
- Equity Capital
- 77
- 5,730
- 0
- Trade Payables
- 1,127
- 6,957
- Total Liabilities
- 13,890
- 9,826
- Capital Work in Progress
- 614
- 1,776
- 132
- 637
- Cash & Bank
- 330
- 575
- Total Assets
- 13,890
- Total Debt
- 4,767
- Net Working Capital
- 1,053
- Contingent Liabilities
- 234
- Book Value per Share
- 753.50
- Face Value
- 10.00
- Total Debt
- 4,767
- Net Working Capital
- 1,053
- Contingent Liabilities
- 234
- Book Value per Share
- 753.50
- Face Value
- 10.00
- Equity Capital
- 236
- 8,116
- 0
- Trade Payables
- 1,465
- 14,918
- Total Liabilities
- 24,735
- 18,753
- Capital Work in Progress
- 795
- 2,675
- 170
- 930
- Cash & Bank
- 323
- 1,088
- Total Assets
- 24,735
- Total Debt
- 10,288
- Net Working Capital
- 740
- Contingent Liabilities
- 146
- Book Value per Share
- 70.80
- Face Value
- 2.00
- Total Debt
- 10,288
- Net Working Capital
- 740
- Contingent Liabilities
- 146
- Book Value per Share
- 70.80
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 408 | 270 | 409 | 426 | 805 | 1,149 | 1,389 | 1,570 | 2,078 | |
| Cash from Investing | -227 | -544 | -127 | -324 | -188 | -1,711 | -994 | -870 | -2,658 | -7,037 |
| Cash from Financing | 150 | 168 | -104 | -93 | -280 | 941 | -144 | -250 | 904 | 4,954 |
| 32 | 32 | 40 | -8 | -42 | 34 | 12 | 268 | -184 | -4 | |
| Free Cash Flow | -55 | -187 | 34 | -310 | 426 | -2,516 | 821 | -3,260 | -1,220 | -7,936 |
| OCF / Net Profit | -2.71 | -4.95 | -2.00 | 6.41 | -3.63 | 1.47 | 2.68 | 2.60 | 1.45 | 2.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -92 | -2,553 | -1,545 | -4,839 | -5,750 | -14,111 |
| OCF / Net Profit | -2.71 | -4.95 | -2.00 | 6.41 | -3.63 | 1.47 | 2.68 | 2.60 | 1.45 | 2.27 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -92 | -2,553 | -1,545 | -4,839 | -5,750 | -14,111 |
- 110
- Cash from Investing
- -227
- Cash from Financing
- 150
- 32
- Free Cash Flow
- -55
- OCF / Net Profit
- -2.71
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.71
- Cumulative 5-Year FCF
- 0
- 408
- Cash from Investing
- -544
- Cash from Financing
- 168
- 32
- Free Cash Flow
- -187
- OCF / Net Profit
- -4.95
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.95
- Cumulative 5-Year FCF
- 0
- 270
- Cash from Investing
- -127
- Cash from Financing
- -104
- 40
- Free Cash Flow
- 34
- OCF / Net Profit
- -2.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.00
- Cumulative 5-Year FCF
- 0
- 409
- Cash from Investing
- -324
- Cash from Financing
- -93
- -8
- Free Cash Flow
- -310
- OCF / Net Profit
- 6.41
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 6.41
- Cumulative 5-Year FCF
- 0
- 426
- Cash from Investing
- -188
- Cash from Financing
- -280
- -42
- Free Cash Flow
- 426
- OCF / Net Profit
- -3.63
- Cumulative 5-Year FCF
- -92
- OCF / Net Profit
- -3.63
- Cumulative 5-Year FCF
- -92
- 805
- Cash from Investing
- -1,711
- Cash from Financing
- 941
- 34
- Free Cash Flow
- -2,516
- OCF / Net Profit
- 1.47
- Cumulative 5-Year FCF
- -2,553
- OCF / Net Profit
- 1.47
- Cumulative 5-Year FCF
- -2,553
- 1,149
- Cash from Investing
- -994
- Cash from Financing
- -144
- 12
- Free Cash Flow
- 821
- OCF / Net Profit
- 2.68
- Cumulative 5-Year FCF
- -1,545
- OCF / Net Profit
- 2.68
- Cumulative 5-Year FCF
- -1,545
- 1,389
- Cash from Investing
- -870
- Cash from Financing
- -250
- 268
- Free Cash Flow
- -3,260
- OCF / Net Profit
- 2.60
- Cumulative 5-Year FCF
- -4,839
- OCF / Net Profit
- 2.60
- Cumulative 5-Year FCF
- -4,839
- 1,570
- Cash from Investing
- -2,658
- Cash from Financing
- 904
- -184
- Free Cash Flow
- -1,220
- OCF / Net Profit
- 1.45
- Cumulative 5-Year FCF
- -5,750
- OCF / Net Profit
- 1.45
- Cumulative 5-Year FCF
- -5,750
- 2,078
- Cash from Investing
- -7,037
- Cash from Financing
- 4,954
- -4
- Free Cash Flow
- -7,936
- OCF / Net Profit
- 2.27
- Cumulative 5-Year FCF
- -14,111
- OCF / Net Profit
- 2.27
- Cumulative 5-Year FCF
- -14,111
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -5.82 | -11.54 | -19.74 | 8.11 | -19.76 | 71.65 | 56.50 | 78.58 | 138.25 | 7.56 |
| Book Value (₹) | 200.83 | 193.40 | 173.98 | 183.33 | 164.86 | 368.91 | 425.70 | 530.69 | 753.50 | 70.80 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.91 | 0.79 | 0.76 | 2.31 | 0.64 | 7.08 | 6.56 | 8.20 | 68.71 | 13.53 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 13.83% | 14.76% | 14.84% | 19.90% | 18.21% | 22.63% | 25.89% | 27.21% | 25.35% | 25.26% |
| Net Margin % | -2.89% | -5.25% | -7.52% | 3.15% | -6.47% | 13.75% | 8.93% | 8.64% | 13.12% | 8.87% |
| ROE % | -2.90% | -6.08% | -10.69% | 5.20% | -9.81% | 27.88% | 14.28% | 14.74% | 22.03% | 12.95% |
| ROCE % | 3.63% | 2.67% | 2.38% | 10.69% | 4.13% | 25.71% | 17.99% | 17.98% | 18.89% | 13.93% |
| -1.36% | -2.52% | -3.87% | 1.66% | -2.86% | 9.62% | 5.68% | 5.76% | 8.78% | 4.75% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 32 | 31 | 30 | 27 | 28 | 20 | 23 | 23 | 24 | 28 |
| Inventory Days | 10 | 9 | 8 | 7 | 7 | 5 | 5 | 5 | 5 | 5 |
| Payable Days | 131 | 176 | 226 | 264 | 333 | 201 | 265 | 277 | 245 | 223 |
| -89 | -136 | -188 | -229 | -298 | -176 | -236 | -249 | -216 | -190 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.97x | 1.24x | 1.45x | 1.43x | 1.39x | 0.71x | 0.67x | 0.98x | 0.82x | 1.23x |
| Interest Coverage (x) | 0.62x | 0.45x | 0.39x | 1.52x | 0.58x | 2.96x | 2.78x | 2.64x | 3.43x | 2.36x |
| 2.19x | 1.35x | 1.08x | 1.06x | 0.82x | 0.78x | 1.31x | 1.24x | 1.59x | 1.22x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 10.95% | 12.08% | 14.54% | 12.83% | -10.44% | 119.23% | 20.90% | 28.42% | 33.55% | 25.40% |
| Operating Profit Growth % | 15.87% | 12.53% | 9.24% | 48.56% | -11.46% | 160.10% | 32.07% | 33.34% | 26.48% | 24.43% |
| Net Profit Growth % | -49.32% | -103.39% | -63.94% | 147.36% | -283.73% | 565.87% | -21.52% | 24.28% | 102.86% | -15.27% |
| -14.00% | -98.12% | -71.13% | 141.07% | -343.70% | 462.57% | -21.14% | 39.08% | 75.93% | -94.53% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 5.76x | 6.20x | 5.86x | 4.13x | 4.18x | 1.87x | 1.55x | 2.05x | 2.01x | 3.65x |
- EPS (₹)
- -5.82
- Book Value (₹)
- 200.83
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.91
- Operating Margin %
- 13.83%
- Net Margin %
- -2.89%
- ROE %
- -2.90%
- ROCE %
- 3.63%
- -1.36%
- Debtor Days
- 32
- Inventory Days
- 10
- Payable Days
- 131
- -89
- Debt to Equity (x)
- 0.97x
- Interest Coverage (x)
- 0.62x
- 2.19x
- Revenue Growth %
- 10.95%
- Operating Profit Growth %
- 15.87%
- Net Profit Growth %
- -49.32%
- -14.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 5.76x
- EPS (₹)
- -11.54
- Book Value (₹)
- 193.40
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.79
- Operating Margin %
- 14.76%
- Net Margin %
- -5.25%
- ROE %
- -6.08%
- ROCE %
- 2.67%
- -2.52%
- Debtor Days
- 31
- Inventory Days
- 9
- Payable Days
- 176
- -136
- Debt to Equity (x)
- 1.24x
- Interest Coverage (x)
- 0.45x
- 1.35x
- Revenue Growth %
- 12.08%
- Operating Profit Growth %
- 12.53%
- Net Profit Growth %
- -103.39%
- -98.12%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 6.20x
- EPS (₹)
- -19.74
- Book Value (₹)
- 173.98
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.76
- Operating Margin %
- 14.84%
- Net Margin %
- -7.52%
- ROE %
- -10.69%
- ROCE %
- 2.38%
- -3.87%
- Debtor Days
- 30
- Inventory Days
- 8
- Payable Days
- 226
- -188
- Debt to Equity (x)
- 1.45x
- Interest Coverage (x)
- 0.39x
- 1.08x
- Revenue Growth %
- 14.54%
- Operating Profit Growth %
- 9.24%
- Net Profit Growth %
- -63.94%
- -71.13%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 5.86x
- EPS (₹)
- 8.11
- Book Value (₹)
- 183.33
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.31
- Operating Margin %
- 19.90%
- Net Margin %
- 3.15%
- ROE %
- 5.20%
- ROCE %
- 10.69%
- 1.66%
- Debtor Days
- 27
- Inventory Days
- 7
- Payable Days
- 264
- -229
- Debt to Equity (x)
- 1.43x
- Interest Coverage (x)
- 1.52x
- 1.06x
- Revenue Growth %
- 12.83%
- Operating Profit Growth %
- 48.56%
- Net Profit Growth %
- 147.36%
- 141.07%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 4.13x
- EPS (₹)
- -19.76
- Book Value (₹)
- 164.86
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.64
- Operating Margin %
- 18.21%
- Net Margin %
- -6.47%
- ROE %
- -9.81%
- ROCE %
- 4.13%
- -2.86%
- Debtor Days
- 28
- Inventory Days
- 7
- Payable Days
- 333
- -298
- Debt to Equity (x)
- 1.39x
- Interest Coverage (x)
- 0.58x
- 0.82x
- Revenue Growth %
- -10.44%
- Operating Profit Growth %
- -11.46%
- Net Profit Growth %
- -283.73%
- -343.70%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 4.18x
- EPS (₹)
- 71.65
- Book Value (₹)
- 368.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.08
- Operating Margin %
- 22.63%
- Net Margin %
- 13.75%
- ROE %
- 27.88%
- ROCE %
- 25.71%
- 9.62%
- Debtor Days
- 20
- Inventory Days
- 5
- Payable Days
- 201
- -176
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 2.96x
- 0.78x
- Revenue Growth %
- 119.23%
- Operating Profit Growth %
- 160.10%
- Net Profit Growth %
- 565.87%
- 462.57%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.87x
- EPS (₹)
- 56.50
- Book Value (₹)
- 425.70
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.56
- Operating Margin %
- 25.89%
- Net Margin %
- 8.93%
- ROE %
- 14.28%
- ROCE %
- 17.99%
- 5.68%
- Debtor Days
- 23
- Inventory Days
- 5
- Payable Days
- 265
- -236
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- 2.78x
- 1.31x
- Revenue Growth %
- 20.90%
- Operating Profit Growth %
- 32.07%
- Net Profit Growth %
- -21.52%
- -21.14%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.55x
- EPS (₹)
- 78.58
- Book Value (₹)
- 530.69
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.20
- Operating Margin %
- 27.21%
- Net Margin %
- 8.64%
- ROE %
- 14.74%
- ROCE %
- 17.98%
- 5.76%
- Debtor Days
- 23
- Inventory Days
- 5
- Payable Days
- 277
- -249
- Debt to Equity (x)
- 0.98x
- Interest Coverage (x)
- 2.64x
- 1.24x
- Revenue Growth %
- 28.42%
- Operating Profit Growth %
- 33.34%
- Net Profit Growth %
- 24.28%
- 39.08%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.05x
- EPS (₹)
- 138.25
- Book Value (₹)
- 753.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 68.71
- Operating Margin %
- 25.35%
- Net Margin %
- 13.12%
- ROE %
- 22.03%
- ROCE %
- 18.89%
- 8.78%
- Debtor Days
- 24
- Inventory Days
- 5
- Payable Days
- 245
- -216
- Debt to Equity (x)
- 0.82x
- Interest Coverage (x)
- 3.43x
- 1.59x
- Revenue Growth %
- 33.55%
- Operating Profit Growth %
- 26.48%
- Net Profit Growth %
- 102.86%
- 75.93%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.01x
- EPS (₹)
- 7.56
- Book Value (₹)
- 70.80
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.53
- Operating Margin %
- 25.26%
- Net Margin %
- 8.87%
- ROE %
- 12.95%
- ROCE %
- 13.93%
- 4.75%
- Debtor Days
- 28
- Inventory Days
- 5
- Payable Days
- 223
- -190
- Debt to Equity (x)
- 1.23x
- Interest Coverage (x)
- 2.36x
- 1.22x
- Revenue Growth %
- 25.40%
- Operating Profit Growth %
- 24.43%
- Net Profit Growth %
- -15.27%
- -94.53%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.65x
Documents
Announcements
- Change in Management
2026-08-20 - Manipal Health Enterprises Limited has informed the Exchange about change in Management
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-20 - Press Release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the Company )
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.

